newsfilter
← Latest News
Business Wire·

Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024

- Additional Phase 2 TORREY Open-Label Extension Data to be Presented in Vienna - Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of